Page last updated: 2024-12-06

4-aminobenzhydrazide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Aminobenzhydrazide (4-ABH) is a versatile building block for the synthesis of various heterocyclic compounds. It is a white crystalline solid with a melting point of 178-180 °C. 4-ABH is commonly synthesized by the reaction of 4-nitrobenzoyl chloride with hydrazine hydrate, followed by reduction of the nitro group. 4-ABH exhibits diverse pharmacological activities including anti-inflammatory, analgesic, and anti-tubercular effects. It is also known to possess antioxidant and antitumor properties. 4-ABH has been investigated as a potential therapeutic agent for various diseases. Its ability to inhibit the activity of enzymes involved in inflammation and cancer has attracted significant interest in the research community.'

4-aminobenzhydrazide: a Russian synthetic drug of acylhydrazide group; decreased uterus wt in rats; RN given refers to cpd with specified locants for amino group [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID21450
CHEMBL ID2170241
SCHEMBL ID328628
MeSH IDM0105907

Synonyms (61)

Synonym
BB 0259293
benzoic acid, p-amino-, hydrazide
benzoic acid, 4-amino-, hydrazide
nsc 640
aminostimil
einecs 226-324-4
p-aminobenzoylhydrazine
ai3-52435
brn 0639053
4nphcon2
4-aminobenzoic acid, hydrazide
4-aminobenzohydrazide ,
p-aminobenzoyl hydrazide
para-aminobenzhydrazide
nsc640
4-aminobenzoylhydrazine
5351-17-7
p-aminobenzoic acid hydrazide
wln: znuyqr dz
amben hydrazide
p-aminobenzoic hydrazide
p-aminobenzhydrazide
nsc-640
4-aminobenzoic acid hydrazide
4-aminobenzhydrazide
4-aminobenzoic hydrazide, 95%
myeloperoxidase inhibitor-i
STK075152
A1211
4-aminobenzoylhydrazide
wpbzmcgpfhzrhj-uhfffaoysa-
inchi=1/c7h9n3o/c8-6-3-1-5(2-4-6)7(11)10-9/h1-4h,8-9h2,(h,10,11)
AKOS000119698
BBL003523
4-pobn
A829637
S9874
bdbm50396407
CHEMBL2170241 ,
F1796-0058
FT-0617553
SCHEMBL328628
AM808223
p-amino benzoyl hydrazine
4-aminobenzohydrazide #
DTXSID30201720
mfcd00007606
4-aminobenzoyl hydrazide
SY036768
(4-aminobenzoyl)hydrazide
myeloperoxidase inhibitor 1
HMS3741K15
H10753
4-aminobenzoic hydrazide
p-amino benzhydrazide
AS-57471
EN300-18128
HY-B0880
CS-0012956
p-aminobenzohydrazide
Z57199627

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" However it acts toxically on tumor cells though it is not toxic for intact cells so that its action is different as compared to that of cytotoxic agents."( [Toxicity of para-aminobenzhydrazide and its influence on nucleic acid biosynthesis in cultures of normal and tumor cells].
Filov, VA; Onishchuk, FD; Tret'iakov, AV, 1989
)
0.28
"1 mM SIN-1 were not toxic to MAC-T cells."( Cytotoxic effects of peroxynitrite, polymorphonuclear neutrophils, free-radical scavengers, inhibitors of myeloperoxidase, and inhibitors of nitric oxide synthase on bovine mammary secretory epithelial cells.
Douglass, LW; Ledbetter, TK; Paape, MJ, 2001
)
0.31
"Peroxynitrite, MPO, and histidine are toxic to mammary secretory epithelial cells."( Cytotoxic effects of peroxynitrite, polymorphonuclear neutrophils, free-radical scavengers, inhibitors of myeloperoxidase, and inhibitors of nitric oxide synthase on bovine mammary secretory epithelial cells.
Douglass, LW; Ledbetter, TK; Paape, MJ, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
MyeloperoxidaseHomo sapiens (human)IC50 (µMol)0.30000.02001.88117.6800AID1514843; AID701373
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (15)

Processvia Protein(s)Taxonomy
hydrogen peroxide catabolic processMyeloperoxidaseHomo sapiens (human)
response to yeastMyeloperoxidaseHomo sapiens (human)
hypochlorous acid biosynthetic processMyeloperoxidaseHomo sapiens (human)
respiratory burst involved in defense responseMyeloperoxidaseHomo sapiens (human)
defense responseMyeloperoxidaseHomo sapiens (human)
response to oxidative stressMyeloperoxidaseHomo sapiens (human)
response to mechanical stimulusMyeloperoxidaseHomo sapiens (human)
removal of superoxide radicalsMyeloperoxidaseHomo sapiens (human)
response to foodMyeloperoxidaseHomo sapiens (human)
response to lipopolysaccharideMyeloperoxidaseHomo sapiens (human)
low-density lipoprotein particle remodelingMyeloperoxidaseHomo sapiens (human)
hydrogen peroxide catabolic processMyeloperoxidaseHomo sapiens (human)
negative regulation of apoptotic processMyeloperoxidaseHomo sapiens (human)
defense response to fungusMyeloperoxidaseHomo sapiens (human)
response to gold nanoparticleMyeloperoxidaseHomo sapiens (human)
defense response to bacteriumMyeloperoxidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
chromatin bindingMyeloperoxidaseHomo sapiens (human)
peroxidase activityMyeloperoxidaseHomo sapiens (human)
protein bindingMyeloperoxidaseHomo sapiens (human)
heparin bindingMyeloperoxidaseHomo sapiens (human)
heme bindingMyeloperoxidaseHomo sapiens (human)
metal ion bindingMyeloperoxidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
extracellular regionMyeloperoxidaseHomo sapiens (human)
extracellular spaceMyeloperoxidaseHomo sapiens (human)
nucleusMyeloperoxidaseHomo sapiens (human)
nucleoplasmMyeloperoxidaseHomo sapiens (human)
lysosomeMyeloperoxidaseHomo sapiens (human)
secretory granuleMyeloperoxidaseHomo sapiens (human)
azurophil granule lumenMyeloperoxidaseHomo sapiens (human)
azurophil granuleMyeloperoxidaseHomo sapiens (human)
intracellular membrane-bounded organelleMyeloperoxidaseHomo sapiens (human)
extracellular exosomeMyeloperoxidaseHomo sapiens (human)
phagocytic vesicle lumenMyeloperoxidaseHomo sapiens (human)
extracellular spaceMyeloperoxidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1059234Lipophilicity, log P of the compound2013European journal of medicinal chemistry, , Volume: 70Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
AID765674Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of HOCl-induced oxidation of APF after 6 mins by fluorescence assay2013European journal of medicinal chemistry, Sep, Volume: 67Modulation of human neutrophils' oxidative burst by flavonoids.
AID1059233Antitubercular activity against Mycobacterium tuberculosis BCG2013European journal of medicinal chemistry, , Volume: 70Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
AID1514843Inhibition of MPO in human neutrophils using H2O2 as substrate measured after 5 mins2019Bioorganic & medicinal chemistry letters, 01-01, Volume: 29, Issue:1
The development of myeloperoxidase inhibitors.
AID765681Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of ROS-induced luminol oxidation incubated for 5 mins prior to PMA challenge by chemiluminescence assay2013European journal of medicinal chemistry, Sep, Volume: 67Modulation of human neutrophils' oxidative burst by flavonoids.
AID701373Inhibition of recombinant human myeloperoxidase2012Journal of medicinal chemistry, Aug-23, Volume: 55, Issue:16
Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening.
AID1264485Reversible inhibition of human recombinant myeloperoxidase at 6 uM for 1 hr followed by washout by ELISA in presence of 50 uM H2O22015ACS medicinal chemistry letters, Oct-08, Volume: 6, Issue:10
Thioxo-dihydroquinazolin-one Compounds as Novel Inhibitors of Myeloperoxidase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (9.09)18.7374
1990's5 (15.15)18.2507
2000's9 (27.27)29.6817
2010's15 (45.45)24.3611
2020's1 (3.03)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.27 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.78%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (97.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]